Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

Understanding proteins linked to PCOS symptoms can improve diagnosis and treatment.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

MicroRNAs could help assess and manage multiple chronic diseases.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Large prostate links to more hair loss, but age of onset doesn't affect it.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Women with high androgen levels may have more severe COVID-19 symptoms.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Men with urinary symptoms are more likely to have erectile dysfunction, and there's a debate about research methods and authorship ethics.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Higher cholesterol levels increase aggressive prostate cancer risk.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.